期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

C1q肾病的诊断及治疗 被引量：4

Diagnosis and treatment of C1q nephropathy
原文传递
导出
摘要 C1q肾病是一种以系膜增生为主的肾小球疾病,其特点为免疫荧光染色可见系膜区高强度C1q沉积,电镜下可见系膜区电子致密物沉积,根据组织病理学特点主要分为3类,包括微小病变(MCD)、局灶节段性肾小球硬化(FSGS)和免疫介导的增生性肾小球肾炎。C1q肾病的临床表现具有多样性,可表现为肾炎或肾病范围内蛋白尿,伴有或不伴有血尿和肾功能损伤。虽然目前糖皮质激素是治疗C1q肾病的主要方法,但多数研究认为C1q肾病对糖皮质激素治疗反应较差。中西医结合治疗有望提高C1q肾病的疗效。 Clq nephropathy is a glomerular disorder with prominent mesangial proliferation. It is characterized by mesangial dense deposits under electron microscopy and Clq deposits under immunofluorescence microscopy. The histologic pattern of Clq nephropathy can be divided into three kinds： minimal change disease （MCD）, focal segmental glomerulosclerosis （FSGS）, and immune-mediated proliferative glomerulonephritis. Its clinical presentation is heterogenous, ranging from nephritic to nephrotic proteinuria, with or without hematuria and renal insufficiency. Glucocorticoids remain the mainstay of treatment. Most studies indicated poor response of Clq nephropathy to glucocorticoids. The treatment of integrated Chinese and western medicine for C1 q nephropathy is promising.
作者 倪兆慧 金海姣 徐维佳
机构地区 上海交通大学医学院附属仁济医院肾脏科
出处 《中华肾病研究电子杂志》 2015年第5期10-13,共4页 Chinese Journal of Kidney Disease Investigation（Electronic Edition）
基金 国家自然科学基金(81370794) 国家科技支撑计划课题(2011BAI10B08)
关键词 C1Q肾病 临床表现 组织学特点 治疗 C1 q nephropathy Clinical presentation Histologic pattern Treatment
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献17

  • 1Malleshappa P, Vankalakunti M. Diverse clinical and histology presentation in Clq nephropathy [ J ]. Nephrourol Mon, 2013,5 (3) : 787-791.
  • 2Jennette JC, Hipp CG. C1 q nephropathy: a distinct pathologic entity usually causing nephrotie syndrome [ J]. Am J Kidney Dis, 1985,6 (2) : 103-110.
  • 3Markowitz GS, Sehwimmer JA, Stokes MB, et al. C1 q nephropathy: a variant of focal segmental glomerulosclerosis [ J ]. Kidney Int, 2003,64(4) : 1232-1240.
  • 4Meyrier A, Gerald BA. Minimal change variants: mesangial proliferation; IgM nephropathy [ DB/OL]. UpToDate, 2014, http ://www. uptodate, corn/contents/.
  • 5Kersnik Levart T, Kenda RB, Avgustin Cavic M, et al. C1Q nephropathy in children [ J ]. Pediatr Nephrol, 2005,20 ( 12 ) : 1756 - 1761.
  • 6van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, et al. Both IgG-and Clq-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells [ J]. J Am Soc Nephrol, 1996,7(4) : 573-581.
  • 7Thomas DB. Focal segmental glomemlosclerosis: a morphologic diagnosis in evolution [ J ]. Arch Pathol Lab Med, 2009,133 ( 2 ) : 217-223.
  • 8Isaac J, Shihab FS. De novo Clq nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy [J] .9 Nephron,2002,92(2) : 431-436.
  • 9Mii A, Shimizu A, Masuda Y, et al. Current status and issues of Clq nephropathy [J]. Clin Exp Nephrol,2009,13(4) : 263-274.
  • 10Vizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of Clq nephmpathy [J]. J Am Soc Nephm1,2008,19 ( 11 ) : 2237-2244.

二级参考文献20

  • 1Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologicentity usually causing nephritic syndrome.Am J Kidney Dis,1985,6:103-110.
  • 2Wenderfer SE,Swinford RD,Braun MC.C1q nephropathy in the pediatric population: pathology and pathogenesis.Pediatr Nephrol,2010,25:1385-1396.
  • 3Mii A,Shimizu A,Masuda Y,et al.Current status and issues of C1q nephropathy.Clin Exp Nephrol,2009,13:263-274.
  • 4Vizjak A,Ferluga D,Rozic M,et al.Pathology,clinical presentations,and outcomes of C1q nephropathy.J Am Soc Nephrol,2008,19:2237-2244.
  • 5Kersnik Levart T,Kenda RB,Avqustin Cavic M,et al.C1q nephropathy in children.Pediatr Nephrol,2005,20:1756-1761.
  • 6Wong CS,Fink CA,Baechle J,et al.C1q nephropathy and minimal change nephrotic syndrome.Pediatr Nephrol,2009,24:761-767.
  • 7Hisano S,Fukuma Y,Segawa Y,et al.Clinicopathologic correlation and outcome of C1q nephropathy.Clin J Am Soc Nephrol,2008,3:1637-1643.
  • 8Sharman A,Furness P,Feehally J. Distinguishing C1qnephropathy from lupus nephritis.Nephrol Dial Transplant,2004,19:1420-1426.
  • 9Weening JJ,D'agati D,Schwartz M,et al.The classification of glomerulonephritis in systemic lupus erythematosus revisited.Kidney Int,2004,65:521-530.
  • 10Isaac J,Shihab FS.De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient:BK virusinduced nephropathy? Nephron,2002,92:431-436.

共引文献6

同被引文献36

  • 1陈香美.中国肾脏病进展.中华医学会肾脏病学分会2011年学术年会专题汇编,北京,2011:1-2.
  • 2Devuyst O, Knoers Nine VAM, Remuzzi G, et al. Rare inherited kidney diseases : challenges, opportunities, and perspectives [ J ]. Lancet, 2014, 383(9931) : 1844-1859.
  • 3Schieppati A, Henter JI, Daina E, et al. Why rare diseases are an important medical and social issue [J]. Lancet, 2008, 371 (9629) : 2039-2041.
  • 4Machuca E, Benoit G, Antignac C. Genetics of nephritic syndrome : connecting molecular genetics to podocyte physiology [ J]. Hum Mol Genet, 2009, 18(It2): R185-R194.
  • 5Stechman M J, Loh NY, Thakker RV. Genetic causes of hypercalciuria nephrolithiasis [ J ]. Pediatr Nephrol, 2009, 24 (12) : 2321-2332.
  • 6Hen'era GA, Turbat-Herrera EA. Renal diseases with organized deposits [J]. Arch Pathol Lab Med, 2010, 134(4) : 512-531.
  • 7Harada M, Kamijo Y, Ehara T, et al. A ease of podoeytie infolding glomerulopathy with multiple myeloma [J].BMC Nephrol, 2014, 15 : 32-35.
  • 8Larsen CP, Bell JM, Harris AA, et al. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation [ J]. Modem Pathol, 2011, 24 ( 11 ) : 1462-1469.
  • 9Klimtchuk ES, Gursky O, Patel RS, et al. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immuglobin light chain [J].Biochemistry, 2010, 49 (45) : 9848- 9850.
  • 10Bekheimia MR, Reed B, Gregoey MC, et al. Genotype-phenotype eorrelation in X-linked Alport syndrome [J].J Am Soc Nephtol, 2010, 21(5) : 876-883.

引证文献4

二级引证文献1

中华肾病研究电子杂志
2015年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部